New Delhi: India may soon start immunization of children above 12 years of age. Bengaluru-based pharmaceutical company Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) for emergency use of its DNA vaccine. If this vaccine is approved, then immunization of 12+ children can be started in the country.
DNA-plasmid based ‘Zykov-D’ There will be three doses of the vaccine. It can be kept at a temperature of two to four degrees Celsius and there will be no need for cold chain. With this, its consignment can be easily transported to any part of the country. The vaccine is supported by the National Biopharma Mission (NBM) under the Biotechnology Industry Research Assistance Council (BIRAC), an undertaking under the Department of Biotechnology.